Haemonetics Corporation (HAE)

Operating profit margin

Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
Operating income US$ in thousands 221,817 164,883 156,033 80,750 57,963
Revenue US$ in thousands 1,360,820 1,309,060 1,168,660 993,196 870,463
Operating profit margin 16.30% 12.60% 13.35% 8.13% 6.66%

March 31, 2025 calculation

Operating profit margin = Operating income ÷ Revenue
= $221,817K ÷ $1,360,820K
= 16.30%

Haemonetics Corporation's operating profit margin has shown a positive trend over the past five years. The margin increased from 6.66% as of March 31, 2021, to 16.30% as of March 31, 2025. This indicates that the company has been able to improve its operational efficiency and profitability over the years. The significant growth in operating profit margin from 2021 to 2025 suggests that Haemonetics has been effectively managing its operating expenses and generating higher revenues relative to its operating costs. This upward trend in operating profit margin reflects Haemonetics' ability to increase profitability and efficiency in its core operations.